STATEMENT: icotec Medical appoints Christoph Eigenmann as new CEO in the United States

(Information sent by the signatory company).

STATEMENT: icotec Medical appoints Christoph Eigenmann as new CEO in the United States

(Information sent by the signatory company)

- icotec Medical appoints Christoph Eigenmann as new CEO in the United States and promotes Carter Lonsberry to executive chairman of the board of directors

ALTSTAETTEN, Switzerland and EAST HARTFORD, Conn., Feb. 7, 2024 /PRNewswire/ -- icotec ag, the leading company in the field of innovative spinal tumor implants, is pleased to announce the appointment of Christoph Eigenmann as its new CEO for the United States. The company also proudly announces the promotion of Carter Lonsberry to executive chairman of the board, signaling a significant strengthening of his leadership team.

Christoph Eigenmann joins icotec Medical with an impressive track record in the medical technology industry. With more than two decades of experience, including senior positions at Johnson

Carter Lonsberry, who successfully led icotec US for the first two years, is appointed CEO of the US board of directors. His promotion is a testament to his invaluable contributions to the future of the company in the United States. In his new role, Carter Lonsberry will continue to shape strategic initiatives.

A new era of innovation and growth

With these key leadership changes, icotec Medical is poised for a new era of growth and innovation. The company, recognized for its BlackArmor® Carbon/PEEK implants, is at the forefront of spinal care, offering innovative solutions for complex spinal conditions.

Roger Stadler, CEO of the icotec ag ​​group, expressed his enthusiasm: "We are delighted to welcome Christoph Eigenmann as our new CEO in the United States. His leadership and experience are exactly what we need to expand our presence in the US market. Additionally, Carter Lonsberry's promotion to the executive board reflects our commitment to developing internal talent and strategic leadership."

Commenting on his new role, Christoph Eigenmann said: "I am very excited to join icotec Medical. icotec is a clear innovation leader in the spine space and I look forward to leading its US team and contributing to the global success of the company".

Carter Lonsberry commented, "I am honored by this promotion and excited to contribute to the strategic direction of the company at an executive level."

icotec Medical Inc. is a wholly owned subsidiary of icotec ag, Switzerland.icotec is the leading company in the treatment of spinal tumors with a new generation of high-tech implants. With its BlackArmor® Carbon/PEEK implants, icotec combines cutting-edge technologies and industry experience to offer innovative and reliable solutions for spine surgeons and their patients and is dedicated to advancing the field of spinal implantation. With a track record of clinical success and a commitment to continuous innovation, icotec is poised to shape the future of spine surgery. The comprehensive product portfolio has received FDA approval and is supported by numerous key opinion leaders and cancer therapy centers around the world. More information can be found at

Contact information

Remo Keller, Group CFO,, 41 71 757 00 96

Photo - - - 945083/...

View original content: